Literature DB >> 14751251

Clinico-molecular study of dedifferentiation in well-differentiated liposarcoma.

Takashi Shimoji1, Hiroaki Kanda, Tomoyuki Kitagawa, Koji Kadota, Ryoichi Asai, Katsutoshi Takahashi, Noriyoshi Kawaguchi, Seiichi Matsumoto, Yoshihide Hayashizaki, Yasushi Okazaki, Kenichi Shinomiya.   

Abstract

Well-differentiated liposarcoma (WD) acquires fully malignant potential when the histological progression named dedifferentiation occurs. This progression is supposed to occur in a time-dependent manner but this is still a debated issue. Clinically, the prediction of dedifferentiation for WD is very important from the therapeutic point of view. To identify genes that are predictive of dedifferentiation and to understand the mechanism of dedifferentiation, we investigated clinical information of 50 cases and studied the gene expression profiles of 36 lipomatous tumors using cDNA microarray. The clinical study showed that the dedifferentiation did not always seem to occur in a time-dependent manner. Interestingly, from the gene expression study, unsupervised hierarchical clustering analysis of well-differentiated lesions obtained from dedifferentiated liposarcoma (DD) cases that were indistinguishable from WD pathologically showed a clearly distinct gene expression pattern from WD. Using the pattern-matching program, 1687 genes including 487 known genes were identified, which discriminated WD cases from well-differentiated lipomatous lesions obtained from DD cases. These results suggest that the dedifferentiation may arise from different types of WD that could be distinguished from gene expression profiling but could hardly be classified by the pathological studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14751251     DOI: 10.1016/j.bbrc.2003.12.203

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Liposarcoma: molecular targets and therapeutic implications.

Authors:  Kate Lynn J Bill; Lucia Casadei; Bethany C Prudner; Hans Iwenofu; Anne M Strohecker; Raphael E Pollock
Journal:  Cell Mol Life Sci       Date:  2016-05-12       Impact factor: 9.261

2.  Predicting dedifferentiation in liposarcoma: a proteomic approach.

Authors:  Colt M McClain; David B Friedman; Tahar Hajri; Cheryl M Coffin; Justin M M Cates
Journal:  Virchows Arch       Date:  2013-05-26       Impact factor: 4.064

3.  An experimental model for the study of well-differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors.

Authors:  Tingsheng Peng; Pingyu Zhang; Jeffery Liu; Theresa Nguyen; Svetlana Bolshakov; Roman Belousov; Eric D Young; Xiaoke Wang; Kari Brewer; Delores H López-Terrada; Andre M Oliveira; Alexander J Lazar; Dina Lev
Journal:  Lab Invest       Date:  2010-11-08       Impact factor: 5.662

4.  Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.

Authors:  Princy Francis; Heidi Maria Namløs; Christoph Müller; Patrik Edén; Josefin Fernebro; Jeanne-Marie Berner; Bodil Bjerkehagen; Måns Akerman; Pär-Ola Bendahl; Anna Isinger; Anders Rydholm; Ola Myklebost; Mef Nilbert
Journal:  BMC Genomics       Date:  2007-03-14       Impact factor: 3.969

5.  Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma.

Authors:  Ju-Ae Hwang; Heung-Mo Yang; Doo-Pyo Hong; Sung-Yeon Joo; Yoon-La Choi; Joo-Hung Park; Alexander J Lazar; Raphael E Pollock; Dina Lev; Sung Joo Kim
Journal:  Oncotarget       Date:  2014-10-15

6.  Silhouette Scores for Arbitrary Defined Groups in Gene Expression Data and Insights into Differential Expression Results.

Authors:  Shitao Zhao; Jianqiang Sun; Kentaro Shimizu; Koji Kadota
Journal:  Biol Proced Online       Date:  2018-03-01       Impact factor: 3.244

7.  Retracted Article: miR-199a-3p knockdown inhibits dedifferentiated liposarcoma (DDLPS) cell viability and enhances apoptosis through targeting casein kinase-1 alpha (CK1α).

Authors:  Ye Cao; Jiajia Zheng; Chentao Lv
Journal:  RSC Adv       Date:  2019-07-23       Impact factor: 4.036

8.  Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma cultures.

Authors:  Adrien Daigeler; Ludger Klein-Hitpass; Michael Ansgar Chromik; Oliver Müller; Jörg Hauser; Heinz-Herbert Homann; Hans-Ulrich Steinau; Marcus Lehnhardt
Journal:  BMC Cancer       Date:  2008-10-29       Impact factor: 4.430

9.  Integrated exome and RNA sequencing of dedifferentiated liposarcoma.

Authors:  Makoto Hirata; Naofumi Asano; Kotoe Katayama; Akihiko Yoshida; Yusuke Tsuda; Masaya Sekimizu; Sachiyo Mitani; Eisuke Kobayashi; Motokiyo Komiyama; Hiroyuki Fujimoto; Takahiro Goto; Yukihide Iwamoto; Norifumi Naka; Shintaro Iwata; Yoshihiro Nishida; Toru Hiruma; Hiroaki Hiraga; Hirotaka Kawano; Toru Motoi; Yoshinao Oda; Daisuke Matsubara; Masashi Fujita; Tatsuhiro Shibata; Hidewaki Nakagawa; Robert Nakayama; Tadashi Kondo; Seiya Imoto; Satoru Miyano; Akira Kawai; Rui Yamaguchi; Hitoshi Ichikawa; Koichi Matsuda
Journal:  Nat Commun       Date:  2019-12-12       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.